Marzouk O, Brasch F, Todt I, Goon P K C, Sudhoff H
Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty OWL, Bielefeld University, Campus Klinikum, Bielefeld, Germany.
Department of Pathology, Academic Teaching Hospital Bielefeld, Bielefeld, Germany.
Case Rep Otolaryngol. 2021 Jan 25;2021:6684254. doi: 10.1155/2021/6684254. eCollection 2021.
Temporal bone Schneiderian papillomas (TBSPs) rarely present as a primary tumors arising from the middle ear and mastoid process. The clinical findings and imaging of TBSPs are not specific. Therefore, diagnosis can only reliably be definitively established by histopathology.
To report a novel case of a malignant transformation of TBSP associated with HPV-6 and to present its management. . A 68-year-old woman presented with conductive hearing loss and recurrent right-sided otorrhoea. Initially, we performed a lateral temporal bone resection and obliteration with abdomen fat. Early histology described TBSP associated with HPV-6. Follow-up detected malignant transformation of the Schneiderian papillomatous variant. Postoperative radiotherapy combined with extended temporal bone resection resulted in a disease-free 17-month period of follow-up. . TBSPs are not very specific, and the diagnosis can only reliably be established by histopathology. There is a risk of malignant transformation, and due to the absence of reliable prognostic markers, strict postoperative follow-up is mandatory and should consist of regular otoscopy, nasal endoscopy, and imaging. This case also supports the importance of extended temporal bone resections as salvage surgery, combining radical surgery with radiotherapy for improved survival rates.
颞骨内翻性乳头状瘤(TBSP)极少作为起源于中耳和乳突的原发性肿瘤出现。TBSP的临床表现和影像学表现不具有特异性。因此,只有通过组织病理学才能可靠地明确诊断。
报告一例与HPV-6相关的TBSP恶变的新病例并介绍其治疗方法。一名68岁女性因传导性听力损失和右侧耳漏反复发作就诊。最初,我们进行了颞骨外侧切除术并用腹部脂肪填充。早期组织学检查显示为与HPV-6相关的TBSP。随访发现内翻性乳头状瘤变体发生恶变。术后放疗联合扩大颞骨切除术使随访17个月无疾病复发。TBSP不具有特异性,只有通过组织病理学才能可靠地确诊。存在恶变风险,由于缺乏可靠的预后标志物,严格的术后随访必不可少,应包括定期耳镜检查、鼻内镜检查和影像学检查。本病例也支持扩大颞骨切除术作为挽救性手术的重要性,将根治性手术与放疗相结合以提高生存率。